News | February 10, 2008

Medrad, Possis Medical Sign $361 Million Merger Agreement

February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.

The cash tender offer is for $19.50 per share, or a total equity value of approximately $361 million. The offer price represents a premium of approximately 39 percent over Possis Medical’s average closing price for the 30 days prior to Feb. 8, 2008. The Possis Medical Board of Directors unanimously approved the transaction and will recommend the offer to its shareholders. The parties agreed to commence within the next 10 business days followed by a merger.

Medrad is a provider of contrast injection systems used to diagnose cardiovascular and other diseases. Possis Medical is a provider of mechanical thrombectomy devices used to treat narrowed or blocked arteries and veins.

Medrad says the combination of the two compatible sales organizations and shared target customer groups establishes an expansive footprint in the cardiovascular intervention field. Medrad’s broad international distribution infrastructure offers a platform for the expansion of Possis Medical’s product portfolio into largely underpenetrated international markets. The companies say the combination of Possis Medical’s thrombectomy platform and Medrad’s vascular injection systems offers a complimentary focus on high-pressure intravascular fluid management and represents a broadened base for future development of new and innovative applications.

Headquartered near Minneapolis, Possis Medical last year posted revenues of $67 million and employs approximately 280 people. Unveiled in 1997, Possis Medical’s AngioJet Rheolytic Thrombectomy System is a leading mechanical thrombectomy system. More than 300,000 patients worldwide have been treated with AngioJet therapy. Possis Medical recently launched the AngioJet Ultra System, a new easier-to-use drive unit.

For more information:

Related Content

Penumbra Launches Jet 7 Reperfusion Catheter With Xtra Flex Technology in U.S.
Technology | Thrombectomy Devices | July 25, 2019
Penumbra announced U.S. commercial availability of the Penumbra System’s most advanced technology, the Penumbra Jet 7...
JETi Thrombectomy System Safe and Effective for Deep Vein Thrombosis
News | Thrombectomy Devices | February 12, 2019
A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology Society of Europe (...
Delayed Clot Removal Still Improves Quality of Life Post-Stroke
News | Thrombectomy Devices | February 05, 2019
Stroke survivors have better quality of life three months after their stroke if the clot that caused the stroke was...
An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal.

Feature | Thrombectomy Devices | January 22, 2019 | Dave Fornell, Editor
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but decli
Cerenovus Launches Global Registry for EmboTrap II Revascularization Device
News | Thrombectomy Devices | January 16, 2019
Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry to collect and...
First Commercial Ekos Control Unit 4.0 Products Shipped to Europe
News | Thrombectomy Devices | November 21, 2018
November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell, W
Medtronic MindFrame Capture LP Revascularization Device Recalled.
News | Thrombectomy Devices | May 21, 2018
Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the...
Stryker Trevo Retriever Thrombectomy Device Approved for Stroke Treatment Up to 24 Hours
Technology | Thrombectomy Devices | February 15, 2018
The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo Retriever as a front-line...
Brain-scan guided emergency stroke treatment can save more lives
News | Thrombectomy Devices | January 25, 2018
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...